Mumbai, May 28 (IANS). Alkem Laboratories Ltd on Thursday released its Q4FY26 results. In the January-March quarter, the company’s profits have seen a weakness of 27.7 percent on an annual basis. This is because the company has suffered a one-time loss during the quarter.
“The company has reported a profit of Rs 236 crore in the March quarter of FY26, compared to Rs 306 crore in the same period last fiscal,” the company said in an exchange filing.
Alkem Labs said that the reason for the decline in the company’s profit is a one-time loss of Rs 135 crore incurred during the quarter.
Despite the decline in profits, the company recorded good growth in earnings. Consolidated income from operations in the March quarter increased by 14.6 per cent to Rs 3,603 crore from Rs 3,144 crore recorded in the same period last year.
The company’s EBITDA has increased by 32.2 percent year-on-year to Rs 517 crore, which was Rs 391 crore in the same quarter of the last financial year.
The company’s EBITDA has increased to 14.4 percent in the March quarter, which was 12.4 percent in the same quarter of FY25.
Alkem Labs has declared a final dividend of Rs 10 per share for FY 2026. The total estimated dividend to shareholders will be approximately Rs 119.57 crore.
The company said that the record date has been set for August 7 to determine the shareholders eligible for the final dividend.
The payment of the dividend is subject to the approval of the shareholders at the upcoming Annual General Meeting and its payment will commence from September 1.
Earlier this year, the company had declared an interim dividend of Rs 43 per share in February 2026.
In the previous financial years, Alkem Labs had paid dividends of Rs 8 per share in August 2025, Rs 37 per share in February 2025 and Rs 5 per share in August 2024.
At the same time, the company has also announced the appointment of Madhurima Singh as Executive Director for a period of five years with effect from December 20.
–IANS
abs/
